Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Adv Sci (Weinh). 2022 May;9(15):e2103526. doi: 10.1002/advs.202103526. Epub 2022 Mar 24.
Kidney organoids derived from human pluripotent stem cells (hPSCs) have extensive potential for disease modelling and regenerative medicine. However, the limited vascularization and immaturity of kidney organoids have been still remained to overcome. Extracellular matrix (ECM) can provide mechanical support and a biochemical microenvironment for cell growth and differentiation. Here in vitro methods using a kidney decellularized extracellular matrix (dECM) hydrogel to culture hPSC-derived kidney organoids, which have extensive vascular network and their own endothelial cells, are reported. Single-cell transcriptomics reveal that the vascularized kidney organoids cultured using the kidney dECM have more mature patterns of glomerular development and higher similarity to human kidney than those cultured without the kidney dECM. Differentiation of α-galactosidase A (GLA)-knock-out hPSCs generated using CRISPR/Cas9 into kidney organoids by the culture method using kidney dECM efficiently recapitulate Fabry nephropathy with vasculopathy. Transplantation of kidney organoids with kidney dECM into kidney of mouse accelerates the recruitment of endothelial cells from the host mouse kidney and maintains vascular integrity with the more organized slit diaphragm-like structures than those without kidney dECM. The kidney dECM methodology for inducing extensive vascularization and maturation of kidney organoids can be applied to studies for kidney development, disease modeling, and regenerative medicine.
人多能干细胞(hPSC)衍生的肾类器官在疾病建模和再生医学方面具有广泛的应用潜力。然而,肾类器官的血管化程度有限且不成熟,仍有待克服。细胞外基质(ECM)可为细胞生长和分化提供机械支持和生化微环境。在此,报道了一种使用脱细胞肾脏细胞外基质(dECM)水凝胶培养 hPSC 衍生肾类器官的体外方法,这些肾类器官具有广泛的血管网络和自身的内皮细胞。单细胞转录组学研究表明,与未使用肾脏 dECM 培养的肾类器官相比,使用肾脏 dECM 培养的血管化肾类器官具有更成熟的肾小球发育模式,与人类肾脏的相似度更高。通过使用肾脏 dECM 的培养方法,将使用 CRISPR/Cas9 技术敲除α-半乳糖苷酶 A(GLA)的 hPSC 分化为肾类器官,可有效模拟 Fabry 肾病伴血管病变。将带有肾脏 dECM 的肾类器官移植到小鼠肾脏中,可促进内皮细胞从宿主小鼠肾脏募集,并通过更有组织的裂孔隔膜样结构维持血管完整性,而没有肾脏 dECM 的肾类器官则无法维持血管完整性。该肾脏 dECM 方法可诱导肾类器官的广泛血管化和成熟,可应用于肾脏发育、疾病建模和再生医学的研究。